Some cytokines [such as transforming growth factor beta (TGF-β), interleukin-10 (IL-10), and programmed death-ligand 1 (PD-L1)] are characterized by inhibiting immune cell activity and reducing the recognition and attack of tumor cells, thereby facilitating tumor escape from immune system monitoring (20). This evidence concerns the gene TGFB1 and neoplasm.